Fragment-based whole cell screen delivers hits against M. tuberculosis and non-tuberculous mycobacteria

• Main Authors: Moreira, W, Lim, J.J, Yeo, S.Y, Ramanujulu, P.M, Dymock, B.W, Dick, T
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2020
• Subjects: antimycobacterial agent; antimycobacterial fragment drug; colistin; fluconazole; unclassified drug; vancomycin; Article; atypical Mycobacterium; bactericidal activity; bacterium culture; Candida albicans; controlled study; Cryptococcus neoformans; cytotoxicity; drug design; drug screening; drug selectivity; Escherichia coli; Klebsiella pneumoniae; minimum inhibitory concentration; molecular library; Mycobacterium tuberculosis; nonhuman; Pseudomonas aeruginosa; Staphylococcus aureus; tuberculosis
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/173819
• Institution: National University of Singapore

10.3389/fmicb.2016.01392